Pay in 4 interest-free payments of $7.15 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
Psychiatry 182, 516524
Randomized, double-blind, pilot evaluation of intravenous glutathione in Parkinsons disease
P171: Durable efficacy and safety of DTX301: Long-term follow up of a phase 1/2 trial in adults with ornithine transcarbamylase deficiency
Additionally, intracerebroventricular delivery of Ex-4 has been found to dose-dependently attenuate cue-evoked dopamine activity, further underscoring the direct influence of GLP-1R signaling on neural circuits governing reinforcement and motivation (Konanur et al., 2020)
US$ 20.50
US$ 23.93
US$ 24.94
US$ 20.82
